Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of Karuna Therapeutics's KarXT?
KarXT is a small molecule commercialized by Karuna Therapeutics, with a leading Pre-Registration program in Schizophrenia. According to Globaldata, it...